![]() |
Path | |
GGT |
||
Return to SydPath Homepage |
||
| Contents
|
Physiology Raised levels of GGT in the blood are a sensitive indicator of liver disease. Together with alkaline phosphatase (ALP), GGT is a marker of cholestasis. Any blockage to the flow of bile, inside or outside the liver, will lead to induction of these enzymes and increased levels in the blood. In these conditions GGT and ALP tend to be elevated to similar levels. If the obstruction is within the liver, there is usually little rise in the serum bilirubin. This is on contrast to extra-hepatic biliary obstruction where the serum bilirubin is usually elevated. Serum levels of GGT are commonly elevated in patients with acute hepatitis although the rise in GGT is usually less than that of the transaminases and rarely exceeds a level of 5 times the upper reference limit. GGT concentrations in serum may also be elevated in response to many drugs and toxins. The usual mechanism for this effect is induction of the enzyme leading to increased production and release into the circulation. Drugs which lead to increased GGT may also lead to an increase in ALP although this does not always occur. Alcohol is a potent inducer of GGT and the enzyme is commonly elevated in regular drinkers. Prescription medications which may lead to increased circulating GGT include dilantin, phenobarbitone, steroids (including the oral contraceptive pill), trimethoprim/sulphomethoxazole, erythromycin and flucloxacillin. Circulating levels may be reduced by cimetidine therapy. GGT levels will show a significant reduction one to two weeks after cessation of a causative agent. GGT may also be released into the circulation from the kidneys and the prostate, eg in patients with renal infarct or prostate cancer. Myocardial infarction, cardiac failure, diabetes and pancreatitis can also increase serum GGT, although in these cases the source of GGT is the liver. GGT levels are higher in overweight people and also responds more markedly to alcohol ingestion in these people. Elevated Serum GGT top of page
Reference: Ruppin DC, Frydman MI and Lunzer MR. Value of serum
gamma-glutamyltransferase in the diagnosis of hepatobiliary disease. MJA 1982;1:421-4. For further information please contact Dr Graham Jones on 8382-9100 |
| Last updated 29/2/00 |